Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients

Research article

Diana Carmona-Fernandes^†, Maria J Santos^†, Inês P Perpétuo, João E Fonseca and Helena Canhão^*

Arthritis Research & Therapy 2011, 13:R175 doi:10.1186/ar3500

No comments have yet been made on this article.